• HOME
  • Products
  • Anti human PON1 (Paraoxonase-1) monoclonal antibody

useful for research of arteriosclerosis, and vascular disorder in renal failure and diabetic

Anti human PON1 (Paraoxonase-1) monoclonal antibody


print

Background

Paraoxonase 1 (PON1) is synthesized primary in the liver and secreted into the plasma. This enzyme is associated with Apolipoprotein A-1 on High Density Lipoproteins(HDL) and hydrolyses paraoxon to p-nitrophenol. The PON1 polymorphism may be responsible for neurodegeneration and considered to be an independent risk factor for Parkinson's disease. Recently it is reported that PON1 suppresses oxidation of Low Density Lipoproteins (LDL) by experiment with knock-out mouse and suggested it works as antioxidant and prevents inflammatory reaction in the blood vessel by hydrolyzing oxidized lipid in LDL.

Western Blot:
1/1,000. Predicted molecular weight: 39.7kDa

Primary antibody :
Anti human PON1 monoclonal antibody (×1,000)
Secondary antibody :
Goat anti-mouse IgG-HRP (×2,500)

Product List

Product Name Cat# Quantity Price

Anti PON1, Human (Mouse) Unlabeled DataSheet

CAC-ABN-M02-HP

100 UG ¥50,000
$667

To be used for research only. DO NOT use for human gene therapy or clinical diagnosis.



“Anti human PON1 (Paraoxonase-1) monoclonal antibody” also belongs to the following categories.